Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD
Starting soon
Conditions studied: Essential Phospholipid in Metabolic Associated Fatty Liver Disease
In brief
To evaluate the efficacy of Essential phospholipid versus Betaine HCL/L-Glutamic Acid in MAFLD
Key facts
- Study ID
- NCT07194863
- Run by
- Assiut University
- People needed
- 200
- Starts
- 2026-11-01
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2026-01-13
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All patients aged >18 years old
- diagnosed as fatty liver based on clinical examination, laboratory investigations and imaging techniques.
You may not qualify if…
- Patients aged ≤18 years old.
- Pregnancy.
- Presence of malignancy.
- Type I DM.
- Fatty liver patients on treatment by statin derivatives or other medications.
- Fatty liver patients undergone bariatric surgeries
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.